Immune-mediated and autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, psoriasis, and atopic dermatitis, occur when the immune system mistakenly attacks the body, causing persistent pain, skin irritation, discomfort, and reduced quality of life. In Australia,
arthritis alone affects around 3.7 million people, and
psoriasis impacts over 600,000 individuals. For many, standard treatments don't provide full relief, leaving them searching for better options.
This autoimmune disease clinical trial is evaluating a potential investigational therapy designed to restore balance in the immune system, rather than broadly suppressing it. By understanding how the body processes the medication, how it affects immune function, and whether the body develops antibodies to it, researchers hope to pave the way for more targeted treatment advances for people living with these conditions.
